Lam, Sze-Kwan
Yan, Sheng
Xu, Shi
U, Kin-Pong
Cheng, Paul Ning-Man
Ho, James Chung-Man http://orcid.org/0000-0003-4499-5284
Funding for this research was provided by:
Hong Kong Anti-Cancer Society, HKSAR
Article History
Received: 8 November 2018
Revised: 30 January 2019
Accepted: 8 February 2019
First Online: 26 February 2019
Conflict of interest
: P.N.-M.C. is the Chief Executive Officer of Bio-Cancer Treatment International Limited. K.-P.U. was a Scientific Officer of Bio-Cancer Treatment International Limited. The remaining authors declare no conflict of interests.